Study of Difluprednate in the Treatment of Uveitis
Phase 3
Completed
- Conditions
- Uveitis
- Registration Number
- NCT00501579
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Brief Summary
The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diagnosis of endogenous anterior uveitis in at least 1 eye
Exclusion Criteria
- Presence of intermediate uveitis, posterior uveitis or panuveitis
- Corneal abrasion
- Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease
- Allergy to similar drugs, such as other corticosteroids
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
John-Kenyon American Eye Institute
🇺🇸New Albany, Indiana, United States